News & Press

AQS³®pro offers breakthrough in bioanalytical technology at WCBP 2019

The WCBP Symposium series was created to address issues at the interface of analytical development and global regulatory for biotechnology-derived health intervention products. The goal was to provide a forum for discussing the latest bioanalytical methods and their practical application to biotechnology pharmaceuticals and other health related products.

Our AQS³pro was a cutting edge addition to the new and existing technologies being showcased.  This included both method and instrumental advances that are used for product characterization, process development, in-process analysis and validate release and stability testing.

Interested in learning more about how the AQS³pro fits into the technology landscape? Contact our team at info@redshiftbio.com.

Want to Join Our Team?